| abstract |
The present invention contains 2-amino-2- [2- (4-octylphenyl) ethyl] propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof, and lecithin as active ingredients, It relates to a pharmaceutical composition containing a sugar accordingly. The pharmaceutical composition of the present invention can be formulated into a liquid formulation and is useful for suppressing rejection at the time of organ or bone marrow transplantation, immunosuppressive maintenance therapy or the treatment of autoimmune diseases. |